产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 |
CAS No. |
2489404-97-7 |
|---|---|
中文名称 |
(R)-5-(1-氟-3-羟基--7-(异戊基氨基)-5,6,7,8-四氢萘-2-基)-1,2,5-噻二唑烷-3-酮 1,1-二氧化物 |
英文名称 |
(R)-5-(1-Fluoro-3-hydroxy-7-(isopentylamino)-5,6,7,8-tetrahydronaphthalen-2-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide |
别名 |
1,2,5-Thiadiazolidin-3-one, 5-((7R)-1-fluoro-5,6,7,8-tetrahydro-3-hydroxy-7-((3-methylbutyl)amino)-2-naphthalenyl)-, 1,1-dioxide | F89382 | CS-0435243 | GTPL11968 | 5-{(7R)-1-fluoro-3-hydroxy-7-[(3-methylbutyl)amino]-5,6,7,8-tetrahydronaphthalen-2-yl}-1la |
标准英文名 |
(R)-5-(1-fluoro-3-hydroxy-7-(isopentylamino)-5,6,7,8-tetrahydronaphthalen-2-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide |
分子式 |
C17H24FN3O4S |
分子量 |
385.46 |
精确分子量 |
385.15 |
SMILES |
CC(C)CCN[C@@H]1CCC2=CC(O)=C(N3CC(=O)NS3(=O)=O)C(F)=C2C1 |
标准SMILES |
CC(C)CCN[C@@H]1CCC2=CC(O)=C(C(F)=C2C1)N1CC(=O)NS1(=O)=O |
用途 |
ABBV-CLS-484 is administered at a recommended dose in subjects with locally advanced or metastatic, recurrent, or refractory head and neck squamous cell carcinoma (HNSCC), recurrent or refractory non-small cell lung cancer (NSCLC), and advanced clear cell renal cell carcinoma (ccRCC). |
InChIKey |
DVFCRTGTEXUFIN-GFCCVEGCSA-N |
|
|
评论 |
|---|